Sinocare Beheer

Beheer criteriumcontroles 4/4

De CEO Sinocare's is Shao Bo Li, benoemd in Aug2002, heeft een ambtstermijn van 22.17 jaar. bezit rechtstreeks 25.76% van de aandelen van het bedrijf, ter waarde CN¥ 4.32B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 16.2 jaar en 4.8 jaar.

Belangrijke informatie

Shao Bo Li

Algemeen directeur

CN¥326.1k

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	22.2yrs
Eigendom CEO	25.8%
Management gemiddelde ambtstermijn	16.2yrs
Gemiddelde ambtstermijn bestuur	4.8yrs

Recente managementupdates

Recent updates

CEO

Shao Bo Li (59 yo)

22.2yrs

Tenure

CN¥326,100

Compensatie

Mr. Shao Bo Li serves as the Chairman and General Manager at Sinocare Inc. since August 07, 2002.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Shao Bo Li	Chairman & GM	22.2yrs	CN¥326.10k	25.76% CN¥ 3.9b
Shi Min Wang	Deputy General Manager	16.2yrs	CN¥318.40k	0.14% CN¥ 21.3m
Jianwen Cai	Deputy General Manager	4yrs	CN¥2.27m	geen gegevens
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	no data	geen gegevens	geen gegevens
Chungeng Chen	Supervisor & Supply Chain Director	no data	geen gegevens	geen gegevens

16.2yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 300298 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 16.2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Shao Bo Li	Chairman & GM	22.2yrs	CN¥326.10k	25.76% CN¥ 3.9b
Baishen Ouyang	Chairman of the Supervisory Board & Assistant to the GM	7.8yrs	geen gegevens	geen gegevens
Chungeng Chen	Supervisor & Supply Chain Director	6.5yrs	geen gegevens	geen gegevens
Hong Yuan	Independent Director	4.8yrs	CN¥120.00k	geen gegevens
Hongjing Che	Non-Independent Director	9.1yrs	CN¥120.00k	0.051% CN¥ 7.8m
Hui Li	Non-Independent Director	4.8yrs	CN¥120.00k	geen gegevens
Xixiong Kang	Independent Director	4.8yrs	CN¥120.00k	geen gegevens
Jizheng Chen	Independent Director	1.8yrs	CN¥120.00k	geen gegevens
Xinyi Li	Vice Chairman	1.8yrs	CN¥565.40k	geen gegevens

4.8yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 300298 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

Sinocare Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Approves Board Elections

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.26 in 3Q 2023)

Investor sentiment deteriorates as stock falls 15%

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Sinocare Inc. to Report Q3, 2024 Results on Oct 24, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.19 in 2Q 2023)

Sinocare Inc. to Report First Half, 2024 Results on Aug 29, 2024

Sinocare Inc. Announces Dividend Implementation for 2023, Payable on 17 June 2024

Sinocare Inc., Annual General Meeting, May 21, 2024

Sinocare Inc. Proposes Final Dividend for 2023

First quarter 2024 earnings released: EPS: CN¥0.15 (vs CN¥0.12 in 1Q 2023)

Investor sentiment improves as stock rises 16%

Sinocare Inc. to Report Q1, 2024 Results on Apr 26, 2024

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Sinocare Inc. to Report Fiscal Year 2023 Results on Apr 26, 2024

Investor sentiment improves as stock rises 19%

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.28 in 3Q 2022)

Now 20% undervalued

Sinocare Inc. to Report Q3, 2023 Results on Oct 24, 2023

Now 20% undervalued after recent price drop

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.26 in 2Q 2022)

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Sinocare Inc. (SZSE:300298) announces an Equity Buyback for CNY 150 million worth of its shares.

Now 21% undervalued after recent price drop

Investor sentiment improves as stock rises 17%

Sinocare Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 26 May 2023

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.19 in FY 2021)

Sinocare Inc. Approves Board Elections

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.14 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.26 (vs CN¥0.13 in 2Q 2021)

Sinocare Inc. Approves Cash Dividend for the Year 2021

Investor sentiment improved over the past week

High number of new directors

Sinocare Inc., Annual General Meeting, May 13, 2022

Sinocare Inc. Proposes Cash Dividend for 2021

Third quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.17 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.079 (vs CN¥0.11 in 1Q 2020)

Investor sentiment deteriorated over the past week

New 90-day low: CN¥31.87

Sinocare Inc. to Report Fiscal Year 2020 Results on Apr 17, 2021

Investor sentiment deteriorated over the past week

New 90-day high: CN¥41.90

Third quarter earnings released

Sinocare Inc. to Report Q3, 2020 Results on Oct 17, 2020

Earnings released

Sinocare Inc. to Report First Half, 2020 Results on Aug 07, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd